SHARE

KKR exits minority stake in biomarker specialist Nordic Bioscience, selling to founder Claus Christiansen

KKR has sold its 10% stake in Denmark-based Nordic Bioscience to founder Claus Christiansen. The biotech firm has doubled revenue over five years, expanding in biomarker R&D, clinical diagnostics, and drug development.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.